 |
 |

Acute Follicular Graft-vs-Host Disease
Barry A. S. Lycka, MD;
Valda N. Kaye, MD
Department of Dermatology University of Minnesota 420 Delaware St SE Box 98 Minneapolis, MN 55455-0392
Arch Dermatol. 1988;124(9):1442.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
We read with interest the report of Friedman and coworkers on acute follicular graft-vs-host reaction (disease) that appeared in the May issue of the ARCHIVES.1 We have also seen this complication of bone marrow transplantation in two of our patients.
Both of our patients were men, aged 34 years, who had acute myelogenous leukemia, one with a granulocytic (M2) variant, the other with a monoblastic (M5A) variant. Both patients had failed courses of conventional chemotherapy. They received total body irradiation (8.5 Gy) and high-dose cyclophosphamide therapy (50 mg/kg/d for four consecutive days) prior to receipt of recin-treated autologous bone marrow transplants. Both transplants were complicated by the development of graft-vs-host disease, resulting in adult respiratory distress syndrome and the death of both patients.
Clinically, the first manifestation in both of our patients was flat-topped, follicular, dusky, erythematous papules on the buttocks and the backs of the
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|